{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T11:05:36Z","timestamp":1783249536572,"version":"3.54.6"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.msard.2020.102224","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T11:45:35Z","timestamp":1590234335000},"page":"102224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Treating patients with multiple sclerosis during the COVID-19 pandemic: Assessing the expert recommendations"],"prefix":"10.1016","volume":"43","author":[{"given":"Carlos","family":"Guevara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Silva","family":"Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Naves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2020.102224_bib0001","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000009507","article-title":"Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic","author":"Brownlee","year":"2020","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2020.102224_bib0002","first-page":"329","article-title":"Public health and ethical considerations in planning for quarantine","volume":"78","author":"Cetron","year":"2005","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.msard.2020.102224_bib0003","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1097\/CCM.0b013e3181d20c77","article-title":"Early observational research and registries during the 2009-2010 influenza A pandemic","volume":"38","author":"Fowler","year":"2010","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.msard.2020.102224_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102073","article-title":"The COVID-19 pandemic and the use of MS disease-modifying therapies","volume":"39","author":"Giovannoni","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2020.102224_bib0005","article-title":"Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies","volume":"77","author":"Luna","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.msard.2020.102224_bib0006","series-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","author":"Mehta","year":"2020"},{"key":"10.1016\/j.msard.2020.102224_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102120","article-title":"COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?","author":"Novi","year":"2020","journal-title":"Mult. Scler. Relat. Disord"},{"key":"10.1016\/j.msard.2020.102224_bib0008","article-title":"Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review","author":"Nussbaumer-Streit","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.msard.2020.102224_bib0009","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12961-018-0328-7","article-title":"Rapid guidelines - timely and important guidance needed for setting standards and best practices","volume":"16","author":"Pang","year":"2018","journal-title":"Heal. Res. Policy Syst."},{"key":"10.1016\/j.msard.2020.102224_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.101982","article-title":"Infections in patients diagnosed with multiple sclerosis: A multi-database study","volume":"41","author":"Persson","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2020.102224_bib0011","series-title":"Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?","author":"Ritchie","year":"2020"},{"key":"10.1016\/j.msard.2020.102224_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101613","article-title":"COVID-19 in Latin America: The implications of the first confirmed case in Brazil","author":"Rodriguez-Morales","year":"2020","journal-title":"Travel Med. Infect. Dis"},{"key":"10.1016\/j.msard.2020.102224_bib0013","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.msard.2020.102224_bib0014","first-page":"473","volume":"395","author":"Russell","year":"2020"},{"key":"10.1016\/j.msard.2020.102224_bib0015","series-title":"An Italian programme for COVID-19 infection in multiple sclerosis","author":"Sormani","year":"2020"},{"key":"10.1016\/j.msard.2020.102224_bib0016","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/jnnp-2017-317493","article-title":"Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study","volume":"89","author":"Wijnands","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2020.102224_bib0017","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00415-020-09822-3","article-title":"Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19\/SARS-CoV-2","volume":"267","author":"Willis","year":"2020","journal-title":"J. Neurol"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482030300X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482030300X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:48:21Z","timestamp":1761900501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482030300X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":17,"alternative-id":["S221103482030300X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102224","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treating patients with multiple sclerosis during the COVID-19 pandemic: Assessing the expert recommendations","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102224"}}